Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07049848
What this trial is testing

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
M.D. Anderson Cancer Center 50
Not applicableLooking for participantsNCT07377747
What this trial is testing

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Who this might be right for
Retroperitoneal Liposarcoma
Australia and New Zealand Sarcoma Association 100
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Early research (Phase 1)Ended earlyNCT01469975
What this trial is testing

First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10

Who this might be right for
Sarcoma, Synovial
Centre Leon Berard 20
Large-scale testing (Phase 3)Looking for participantsNCT03805022
What this trial is testing

Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas

Who this might be right for
Non-metastatic Soft-tissue SarcomaResectable
Institut Bergonié 351
Not applicableStudy completedNCT00040911
What this trial is testing

Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma

Who this might be right for
Brain TumorsCentral Nervous System TumorsChildhood Germ Cell Tumor+8 more
Children's Oncology Group 17
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Early research (Phase 1)Study completedNCT00003141
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma+1 more
Children's Oncology Group 94
Early research (Phase 1)Study completedNCT03217266
What this trial is testing

Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Resectable Soft Tissue SarcomaSoft Tissue Sarcoma
National Cancer Institute (NCI) 39
Early research (Phase 1)WithdrawnNCT03782363
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Italian Sarcoma Group
Testing effectiveness (Phase 2)UnknownNCT04294511
What this trial is testing

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Who this might be right for
Osteosarcoma
Sun Yat-sen University 75
Not applicableUnknownNCT05442333
What this trial is testing

Adjuvant Versus Neo-adjuvant Radiotherapy in Patients With Resectable Soft Tissue Sarcoma in Extremities : Wound Complications

Who this might be right for
Resectable Soft Tissue SarcomaExtremitiesRadiotherapy Wound Complications
Ain Shams University 20
Testing effectiveness (Phase 2)WithdrawnNCT06116578
What this trial is testing

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab

Who this might be right for
Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT01005043
What this trial is testing

Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma

Who this might be right for
Osteosarcoma
University Hospital Heidelberg 23
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT03063983
What this trial is testing

Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma

Who this might be right for
Osteosarcoma
Grupo de Apoio ao Adolescente e a Crianca com Cancer 158
Next Page